BCR and neoplasm: We calculated the difference in expression between normal and tumor samples in each tumor and performed differential significance analysis using unpaired Wilcoxon rank-sum and signed rank tests, we observed significant upregulation in 24 tumors (Figure 1(a)), such as GBM, GBMLGG, LGG, UCEC, BRCA, CESC, ESCA, STES, COAD, COADREAD, PRAD, STAD, HNSC, LUSC, LIHC, WT, SKCM, BLCA, READ, PAAD, TGCT, ALL, LAML, and CHOL.